We have used the streptozotocin-induced diabetes mellitus pregnant rat as a model of maternal nonthyroidal illness. We measured the effects of different degrees of diabetes mellitus on maternal body weight, the outcome of pregnancy, circulating glucose, insulin, T 4 , T 3 , rT 3 , and TSH in mother and fetus, T 4 and T 3 in maternal and fetal tissues, and iodothyronine deiodinases in liver, lung, and brain.
The number and body weight of the fetuses, their pituitary GH contents, and their thyroid hormone status were severely affected. The total extrathyroidal T 4 and T 3 pools decreased to one third of normal fetal values. T 4 and T 3 concentrations in the fetal brain were lower than normal, and the expected increase in type II 5Јdeiodinase activity was not observed. The low cerebral T 3 only improved with adequate insulin treatment of the dams.
It is concluded that maternal diabetes mellitus, and possibly other nonthyroidal illnesses that impair the availability of intracellular energy stores, may affect fetal brain T 3 when thyroid hormones are essential for normal development. (Endocrinology 138: 1159 -1169, 1997) D IABETES mellitus leads to alterations of thyroid hormone status typical of other so called nonthyroidal illnesses (1) (2) (3) . The major alterations in thyroid hormone economy are a reduction in the TSH stimulation of the thyroid gland, probably caused by central hypothyroidism, and in the peripheral generation of T 3 from T 4 (3) . The injection of streptozotocin (STZ) in rats is frequently used to obtain an experimental model for the study of diabetes mellitus, often as a model of nonthyroidal illness.
In the STZ-diabetic adult rat, the alterations in the hypothalamo-pituitary-thyroid axis are numerous; hypothalamic and plasma TRH (4, 5) , pituitary and plasma TSH, as well as TSH secretion rate are reduced (4, 6, 7) , and the TSH response to TRH is decreased despite normal peripheral TSH metabolism (6) . T 3 and T 4 production (8) and iodide uptake by the thyroid are diminished. There are also important structural changes in the thyroid gland and pituitary that are accompanied by marked alterations in their secretory activity. In addition, T 4 deiodination to T 3 in peripheral tissues is decreased (8 -10) . As a consequence of all of these changes, circulating levels of T 4 and T 3 are markedly reduced as are the concentrations of both iodothyronines in most tissues (8 -10) .
These alterations have been shown in the adult diabetic rat, but to our knowledge very little is known about the possible influence of maternal diabetes on the thyroid hormone status of the fetus. In a preliminary study (11) we have shown that STZ-induced maternal diabetes mellitus also affects fetal thyroid hormone economy, as studied at 20 days gestation, causing a decrease in T 4 and T 3 in plasma and most fetal tissues, including brain. These preliminary results also suggested that the normal response of 5Ј-deiodinase type II (5ЈD-II) to low T 4 concentrations was impaired in the fetal brain.
The present study has been undertaken to further define the effects of different degrees of maternal nonthyroidal illness, as induced by diabetes mellitus, on fetal thyroid hormone status and their prevention with adequate control of the maternal metabolic imbalances.
Materials and Methods

Experimental design
Female Wistar rats were used for this study. The guidelines for humane treatment of animals were followed, and the study was approved by the committee of our institute. They were maintained at 22 C with 12-h periods of light and darkness. They were mated with normal males, and the morning of appearance of the vaginal plug was considered day 0 of gestation. Thirty pregnant rats were divided into six groups. One group served as normal pregnant controls (C). At 7 days gestation (dg), the other five groups of rats were injected into the femoral vein with 4.5 mg/100 g BW STZ dissolved in 50 mm citrate buffer, pH 4.5 (12) . One of the groups of STZ-treated dams was not injected with insulin and served as the long duration diabetes mellitus (D) group, as 14 days had elapsed since injection of the dams with STZ. A second group of STZ-injected pregnant rats received 1.5 U bovine insulin (Ultralente, Novo Nordisk, Bagsvaerd, Denmark)/100 g BW⅐day, sc, once daily from 9 -15 days gestation and vehicle (Diluting Medium for Lente MC, Novo Nordisk) from 15-20 dg; this group is referred to as sD, for short duration diabetes mellitus, as the dams were left untreated only for the last 5 days. Three groups of rats were injected sc once daily with 0.5, 1.0, or 1.5 U bovine insulin/100 g BW⅐day from 9 -20 dg (Dϩ0.5 Ins, Dϩ1.0 Ins, and Dϩ1.5 Ins groups, respectively). Most results obtained in D and sD groups were very similar, so only results from D dams will be presented; differences between D and sD groups, if any, are indicated in the text, tables, or figure legends.
On the morning of 21 dg and 24 h after the last of the insulin injections, all dams were anesthetized with ether, bled, and perfused with 40 -50 ml 0.05 m phosphosaline buffer, pH 7.4, as previously described (13) .
Maternal plasma, liver, brain, lung, heart, and samples of mammary tissue were obtained and frozen. The uterus was dissected out and carefully rinsed and blotted free of maternal blood. The fetuses were then dissected out, bled, separated from the placenta, weighed, and immediately placed on ice. The fetal brain, liver, and lung were dissected out and quickly frozen on dry ice; the thyroid, adhering to the trachea, was withdrawn and frozen. Two or three fetal thyroids and pancreas from each litter were fixed in toto by immersion in PBS containing 4% formaldehyde for morphological study. The rest of the fetus, referred to here as the carcass (whole embryo minus the blood, trachea, thyroid, liver, lung, brain, and heart) was stored frozen. The placentas were separated, weighed, and divided into the basal (maternal) and labyrinth (fetal) sides with blunt forceps and frozen rapidly, as previously described (14) .
Determination of thyroid hormone concentrations
Thyroid hormone levels were determined by RIAs after extraction and purification of plasma and tissues (15) . In brief, methanol is added to the still frozen tissue sample and homogenized, with tracer amounts of [
131 I]T 4 and [ 125 I]T 3 added to each homogenate. This is followed by the addition of chloroform in a volume double that of methanol, centrifugation, and a further extraction of the pellet with chloroform-methanol (2:1). This extracts more than 90% of the endogenous and added iodothyronines. The iodothyronines are then back-extracted into an aqueous phase and purified by passing this aqueous phase through Bio-Rad AG 1 ϫ 2 resin columns (Bio-Rad, Hercules, CA). After a pH gradient, the iodothyronines are eluted with 70% acetic acid, which is then evaporated to dryness and dissolved in RIA buffer. Each extract is extensively counted to determine the recovery of the [ 131 I]T 4 and [ 125 I]T 3 added to each sample during the initial homogenization process. The samples are submitted to highly sensitive RIAs for the determination of T 4 and T 3 ; the limits of sensitivity are 2.5 pg T 4 and 1.5 pg T 3 /tube. The cross-reactivities of the different iodothyronines and metabolites were as reported previously (15, 16) . Each sample is processed in duplicate or triplicate at two or more dilutions. Concentrations were then calculated using the amounts of T 4 and T 3 found in the respective RIAs, the individual recovery of the [ 131 I]T 4 and [ 125 I]T 3 added to each sample during the initial homogenization process, and the weight of the tissue sample submitted to extraction.
Maternal samples were processed individually. Plasma from different fetuses were pooled to obtain 300-to 400-l aliquots. Fetal tissues were pooled (two or three organs per pool) for the determination of T 4 and T 3 . Pools were obtained from fetuses of the same litter.
The fetal thyroids were pooled in groups of two or three, homogenized, and submitted to proteolytic digestion, followed by methanol extraction. The methanol extracts were submitted to evaporation to dryness in a microwave oven at maximum heat for 5-10 min; this prevents artifacts in the RIAs, presumably due to residual proteolytic activity transferred into the RIA tube. RIA buffer was added, and T 4 and T 3 were determined by RIA, as described above.
Percentage of circulating free T 4 and T 3
These percentages were determined by ultrafiltration of undiluted plasma samples, as described by Mendel et al. (17) Other determinations rT 3 concentrations in maternal and fetal plasma and in placental extracts were determined by RIA, as previously described (14) .
Maternal and fetal plasma glucose levels were determined by the glucose oxidase method (20) , using 10 -25 l plasma.
Insulin levels in maternal and fetal plasma were measured using the specific RIA adapted for rat insulin with reagents supplied by Novo Nordisk (Bagsvaerd, Denmark). We used rat insulin as standard, antiporcine antiserum, and human 125 I-labeled insulin as antigen (18) . A bovine insulin standard was used for the standard curve when the plasma was obtained from mothers injected with bovine insulin.
TSH was determined in 200-l aliquots of maternal plasma, and GH was determined in fetal pituitaries, using the immunoreactants for RIA kindly supplied by the NIH (Bethesda, MD) and made available through the Rat Pituitary Agency of the NIDDK. Concentrations are expressed in weight equivalents of the rat TSH RP-3 and rat GH RP-2 reference preparations (21). 
Drugs and reagents
Statistical analysis
After testing for homogeneity of variance using Bartlett's procedure for groups of unequal size, data were submitted to one-way ANOVA. Square root or logarithmic transformations usually ensured homogeneity of variance when this was not achieved with the raw data. Sig-nificant differences among groups were assessed using the protected least significant difference test. All statistical calculations were performed as described by Snedecor and Cochran (22) . The se appearing in the tables and figures is the mean se calculated by ANOVA and used for the identification of statistically significant differences between groups by the least significant difference test. For the sake of clarity, the Ϯse is shown in figures only on the C value bar.
Possible interrelations among variables were tested by curve fitting of the individual data using Cricket Graph III for Macintosh (Computer Associates International, Inc., Islandia, NY), and the degree of fit was assessed from the corresponding value of r and the degrees of freedom.
Results
Experimental design
The aim of the present experimental design was to induce maternal diabetes mellitus of different duration and degree and to assess the effects of these different degrees of maternal nonthyroidal illness on fetal thyroid hormone status near term. Figure 1 shows the insulin and glucose concentrations in the maternal plasma (M-plasma) from the different groups at 21 dg. Insulin decreased significantly in all D dams. As expected, circulating glucose levels were very high in all STZ-injected dams that did not receive insulin. The injection of insulin affected both insulin and glucose levels in the maternal circulation. Normal levels of insulin, as measured 24 h after the last injection, were found in the Dϩ0.5 Ins or Dϩ1.0 Ins groups, with higher than normal values in the Dϩ1.5 Ins dams. Circulating glucose was somewhat higher than C values in the Dϩ0.5 Ins dams, although markedly decreased compared to those in D animals, and comparable to those in C dams in the Dϩ1.0 Ins and Dϩ1.5 Ins groups. The circulating glucose was inversely related to plasma insulin by a power function (n ϭ 30; r ϭ 0.88; P Ͻ 0.001).
Degree of nonthyroidal illness: diabetic state and weight loss of the dams.
Figure 1 also shows the calculated change, between 7 and 21 dg, in the body weight of the pregnant rats, free of the conceptus (M-BW), namely the total measured weight of the dam minus the weight of the conceptus. The change in M-BW was calculated from data reported in Table 1 , such as the change in total weight, the number of fetuses per litter, the body weights of the fetuses (F-BW), and the weights of the placentas. The weight of the conceptus was calculated for each animal from the sum of the weights of all fetuses and placentas in each dam. Although extraembryonic fluids and membranes had not been collected, the sum of the fetal and placental weights appears to be a reasonable approximation of the total weight of the conceptus. The change in M-BW was calculated by subtracting this calculated weight of the conceptus from the measured change in total weight of the animal. As shown in Fig. 1 , the mean net increase in M-BW of C dams was 27.8 Ϯ 4.3 g. In contrast, in all D dams, there was a net loss of M-BW, which was prevented by insulin treatment.
Both the increment in total weight and the change in M-BW were significantly related to decreasing glucose and increasing insulin concentrations in the maternal circulation and appear to be good indexes of the degree of maternal illness. The closest fit was found for the change in M-BW vs. the logarithm of the M-plasma insulin levels (Fig. 2) .
Effects of maternal illness on the outcome of pregnancy.
No reproductive abnormalities were observed in the normal (C) dams (Table 1 ). There were originally eight dams in the D group, four dams in the sD group, and four each in the three Dϩinsulin groups. Whenever only reabsorbed fetuses or less than two apparently viable fetuses were found in the uterine cavity of these dams, they were excluded from the study. This reduced the number of dams in the D group. The proportion of dams in which such abnormalities were found was more frequent in the D groups. Treatment with insulin only appeared to effectively prevent these abnormalities in the Dϩ0.5 Ins dams, which in these reproductive aspects were comparable to C animals.
The weight of the conceptus (not shown) was lower than normal in D groups. This was due to a smaller number of apparently viable fetuses, a decreased F-BW, or both. Treatment with insulin had variable effects; F-BW improved with respect to the D dams in the Dϩ0.5 Ins and Dϩ1.5 Ins groups, especially in the former, although C values were not reached, whereas both number and F-BW in the Dϩ1.0 Ins group were as poor as in D dams.
The various treatments did not similarly affect the fetal and maternal sides of the placenta. Although mean F-placental weights tended to change in parallel with the total placental weight, the weight of the M-placenta decreased in D groups compared to that in C dams. In the insulin-treated animals, the weight of the M-placenta only increased to normal values in the Dϩ0.5 Ins group and was actually smaller than normal in the Dϩ 1.5 Ins group.
In summary, the outcome of pregnancy was affected by
The mean (ϮSE) circulating insulin and glucose concentrations in the plasma of dams from the different groups are shown. The right panel shows the difference between the change in total weight and the weight that can be attributed to the conceptus. This difference represents the change in the body weight of the mother herself (M-BW) between 7 and 21 dg. In this and the following figures, the SE shown only on the C value bar is the mean SE calculated by ANOVA.
The shaded area corresponds to the mean C value Ϯ SE. *, Statistically significant differences vs. C dams; #, statistically significant differences vs. the D group. Other statistically significant differences are not identified for the sake of clarity. The circulating insulin levels of sD dams (not shown) were very low, but somewhat higher than those of D dams, and the net loss in M-BW in sD dams was also less marked than that in D dams. For insulin or glucose values there was no statistically significant difference between the Dϩ0.5 Ins and Dϩ1.0 Ins dams, whereas insulin and glucose were different in the plasma of Dϩ1.0 Ins vs. Dϩ1.5 Ins animals. There were no statistically significant differences in the change in total body weight, weight of the conceptus, or maternal body weight among the three insulininjected groups, with the exception of the weight of the conceptus in the Dϩ0.5 Ins dams, which was greater than those in the Dϩ1.0 Ins and Dϩ1.5 Ins dams.
the maternal diabetic state and illness. The negative effects were best prevented with the administration of 0.5 U insulin/100 g BW⅐day.
Effects on thyroid hormone status of the mothers
The circulating concentrations of T 4 , T 3 , rT 3 , and TSH as well as the % FT 4 , % FT 4 , % FT 3 , and % FT 3 are shown in Fig.  3 . Figure 4 shows the concentrations of T 4 and T 3 in the liver, lung, brain, heart, and mammary tissue. Iodothyronine deiodinase activities in some maternal tissues are shown in Fig. 5 .
Effects of the diabetic state. Mean values of T 4 , T 3 , and rT 3 in the maternal circulation and of T 4 and T 3 in most tissues studied were lower in D dams than in C mothers, with the differences between C and D dams being statistically significant with few exceptions (brain T 4 and mammary gland T 3 concentrations).
Circulating % FT 4 was increased in the diabetic dams to twice the values normal for the pregnant dam. This increase was comparable to the decrease in total circulating T 4 , as a result of which the mean circulating FT 4 , although lower in D compared to C dams, was not statistically different from that in the C mothers. The % FT 3 also increased in D compared to C dams, but not to the extent that it could compensate for the decrease in circulating total T 3 , and the FT 3 concentration was lower than that in C dams.
5ЈD-I activity in the liver and lung were decreased in the diabetic dams (Fig. 5) , a finding consistent with the decreased hepatic and pulmonary thyroid hormone concentrations. Despite the decreased plasma T 4 concentrations, no significant change was observed in the 5ЈD-II activity of the cortex, a finding consistent with the lack of decrease in the cerebral T 4 concentration. The 5D-III activity of the cortex was not different in D and C dams.
Effects of insulin treatment of the D dams on their thyroid hormone status.
The injection of insulin either normalized circulating T 4 , T 3 , and rT 3 concentrations or resulted in supraphysiologi- a The figures given are those of the number of dams included in the final evaluation of the results of the present study. When only reabsorbed embryos (or fewer than two apparently viable fetuses) were found in the uterine cavity, the dams were excluded from the study; their number minus that initially allotted to each treatment group is shown. This initial figure is given inside parentheses followed, in italics, by the number of dams in which reabsorbed fetuses were found.
b Statistically significant differences (P Ͻ 0.05) vs. C group. Although not shown, the F-BW of sD animals was significantly different. Fig. 1 for the meaning of the shaded area and the symbols. Data for sD dams (not shown) were comparable to those for D dams, except for circulating TSH, which was still comparable to those for C dams. There were no statistically significant differences in the rT 3 and TSH concentrations among the three groups of insulininjected dams. The T 4 and T 3 levels were the same for the Dϩ0.5 Ins and Dϩ1.0 dams, but were higher in the Dϩ1.5 animals.
cal levels (Fig. 3) . Thus, the maternal hypothyroxinemia caused by the diabetic state was avoided in all of the insulintreated D dams. TSH concentrations improved with the injection of insulin, except in the Dϩ1.0 Ins dams. The effects of treatment with insulin depended on the dose used. In the Dϩ0.5 Ins dams, all parameters of thyroid function that were affected by the diabetic condition were maintained within the normal range, with the exception of heart T 4 concentrations, which remained lower than normal. The effects in the two groups on the higher doses of insulin were more variable; higher than normal concentrations of the iodothyronines were often found in plasma and tissues. This occurred at different insulin doses, depending on the tissue and whether T 4 or T 3 concentrations were being considered.
The injection of insulin reversed to normal the decreased liver and lung 5ЈD-I activities or increased this activity to supraphysiological levels in the lung of the Dϩ1.0 dams. On the contrary, the mean 5ЈD-II activity in the maternal cortex decreased with increasing insulin doses; the difference with respect to both D and C dams was significant in the Dϩ1.5 Ins group. The 5D-III activity of the cortex increased in the Dϩ0.5 Ins group above the values found in C and D dams, then decreased in an apparently insulin dose-dependent fashion.
Relationships between the degree of maternal illness and several indexes of maternal thyroid hormone status. To exclude differences related to the duration of the diabetic state, data from sD dams were not used for this evaluation. The changes in all circulating parameters of thyroid status (T 4 , % FT 4 , T 3 , % FT 3 , rT 3 , and TSH) were closely correlated to the degree of maternal diabetes and illness, whether measured by the circulating glucose or insulin levels or the change in M-BW. When the parameters of thyroid hormone status were plotted against the above indexes of maternal metabolic imbalances, data fit linear functions, with values of r ranging from 0.77-0.85 (P Ͻ 0.001 in all cases).
The changes occurring in the activities of liver and lung 5ЈD-I were also closely related to the circulating glucose and insulin levels and the change in M-BW, with r values for the fit to linear functions ranging from 0.75-0.84 (P Ͻ 0.001). In contrast, no such relationships were found between the cerebral cortex 5ЈD-II and 5D-III activities and these indexes of the diabetic state.
Relationships between several indexes of maternal thyroid hormone status. Circulating TSH changed in parallel to plasma T 3 and not inversely, as expected if the negative feedback between the pituitary and thyroid was operative.
Although the patterns of changes in T 4 and T 3 concentrations in tissues appeared similar to those described for their respective circulating levels, we observed that the changes occurring in the different tissues could not be predicted from those in the corresponding plasma levels (total or free). Thus, for instance, the concentrations of T 3 in brain, heart, and mammary tissue of the D dams were at least 2-fold higher than expected from plasma T 3 or FT 3 levels.
Liver 5ЈD-I activity was fitted to a linear function of liver T 3 concentration, with an r ϭ 0.826 (P Ͻ 0.001). The lung 5ЈD-I, cortex 5ЈD-II, and cortex 5D-III levels were more poorly fitted to linear functions when plotted against their tissue or plasma concentration of T 4 and T 3 , with r values 0.60 or less.
Effects on the fetal compartment
Thyroid hormone status of the placenta. Figure 6 shows the concentrations of T 4 , T 3 , and rT 3 in the M-and F-placenta, which decreased in the D dams and returned to normal or are shown for liver, lung, brain, heart, and mammary tissue. The shaded areas and symbols are explained in Fig. 1 . There were no statistically significant differences in the T 4 concentrations found in liver, lung, and brain of dams receiving the various insulin doses. The concentration of T 3 in these tissues was lower in the Dϩ0.5 Ins dams than in the Dϩ1.0 Ins and/or Dϩ1.5 Ins mothers.
FIG. 5. The mean (ϮSE) activities of the outer ring 5ЈD, type I for liver (picomoles of I
Ϫ per min/mg protein) and lung (femtomoles of I Ϫ per h/mg protein), type II for cortex (Cx; femtomoles of I Ϫ per h/mg protein), and Cx inner ring 5D-III (picomoles of I Ϫ per h/mg protein) are shown. The shaded areas and symbols are explained in Fig. 1 . Although decreased in sD dams (not shown) compared to those in C dams, liver and lung 5ЈD-I activities were somewhat higher than those in D animals. There were no insulin dose-related differences in liver or brain 5ЈD activities. The activity in lung in Dϩ1.0 Ins dams was higher than those in Dϩ0.5 and Dϩ1.5 Ins rats.
higher than normal values in DϩIns dams. There were quantitative differences between the M-and F-placenta with regard to the effects of diabetes and the various doses of insulin.
In the F-placenta, the changes in T 4 and rT 3 concentrations are comparable to those described in maternal circulating levels. On the contrary, in the M-placenta, T 4 and rT 3 concentrations were lower than expected from the circulating levels; the concentrations in the M-placenta of D dams decreased more in C dams than the observed change in the respective circulating levels and increased to only half the expected levels with insulin treatment. M-placenta T 4 was only normal in the Dϩ1.5 Ins group, in which the circulating concentrations were clearly above C values. In contrast, T 3 concentrations in the M-placenta of D dams, whether treated with insulin or not, were higher than expected from T 3 circulating levels. Figure 7 shows the plasma glucose and insulin concentrations as well as the GH content of the F-pituitary. F-plasma glucose was markedly elevated in the progenies from D dams. Treatment of the mothers with insulin resulted in a dose-dependent decrease in F-plasma glucose; the fetuses from the Dϩ1.5 Ins dams actually were hypoglycemic compared to those from normal dams, as measured 24 h after the injection of insulin into their mothers. The insulin levels in the fetal circulation were low in the fetuses from D dams, returning to normal in the Dϩ0.5 Ins group, then decreasing in an insulin dose-dependent fashion. The pituitary GH content was lower in fetuses from D dams, with an ameliorating effect observed in fetuses from insulin-infused D dams (except in the Dϩ1.0 Ins group), although pituitary GH content was far from normal values.
Thyroid hormone status of the fetus.
Total thyroidal T 4 and T 3 contents (Fig. 8 ) decreased in the fetuses from the diabetic mothers, with little improvement noted in the insulin-treated groups, except for a normalization of the T 3 content in the Dϩ0.5 Ins and Dϩ1.5 Ins fetuses. The T 4 and T 3 concentrations 1 in the fetal circulation (Fig. 8 ) decreased in the D groups and improved in the fetuses from insulin-treated dams, although not in an insulin dose-dependent fashion. The % FT 4 (not shown) increased from 0.126 Ϯ 0.002% in C fetuses to 0.174 Ϯ 0.016% in fetuses from D dams (P Ͻ 0.01). Unfortunately, there was not enough plasma to measure changes in % T 3 or changes in % T 4 in the other groups.
The T 4 and T 3 concentrations in different F-tissues (Fig. 9 ) decreased in tissues from D groups. Treatment of the mothers with insulin usually resulted in improved T 4 and T 3 concentrations in most F-tissues compared to those in D fetuses. However, in most tissues an insulin dose-dependent effect was not observed, and improvement was minimal in the Dϩ1.0 Ins group. In D fetuses, 5ЈD-activity was lower than normal in F-liver and F-lung (Fig. 9) and were restored to normal values in fetuses from insulin-treated dams, with the exception of Fliver in the Dϩ1.0 Ins group, where it was actually reduced below D levels. 5ЈD-II activity in the F-brain was unchanged, except for a decrease in Dϩ1.0 Ins fetuses. Fetal brain 5D-III activity (not shown) of normal fetuses was 6.09 pmol/h⅐mg protein and did not decrease significantly in fetuses from D dams, but increased slightly with insulin treatment of the mothers to 6.83 pmol/h⅐mg protein (similar results were observed regardless of the insulin dose).
Relationships between fetal and maternal thyroid hormone levels and between parameters of fetal thyroid hormone status
There was a very good correlation between the glucose concentrations in the fetal and maternal circulations (n ϭ 33; r ϭ 0.96; P Ͻ 0.001), but not between insulin levels. The latter was due to the finding that in the insulin-treated groups, insulin levels in M-plasma increased proportionally to the administered dose, whereas they decreased in F-plasma.
The F-BW (Table 1) was affected by the maternal diabetic state. This decrease was not totally corrected with any of the doses of insulin administered to the dams, but the closest to normal F-BW were observed for fetuses from the Dϩ0.5 Ins mothers, and the lowest was found in fetuses from Dϩ1.0 Ins dams. The F-BW was related to other indexes of the outcome of pregnancy, such as the number of viable fetuses per litter (n ϭ 29; r ϭ 0.63; P Ͻ 0.001). F-BW was clearly related to the GH content of the fetal pituitary (Fig. 8) , with a good fit to a linear function of F-BW vs. the logarithm of the GH content (n ϭ 33; r ϭ 0.87, P Ͻ 0.001). With the exception of the F-plasma T 3 level, the T 4 and T 3 concentrations in F-tissues were more closely correlated to the F-BW and pituitary GH content than to the changes in maternal thyroid hormone status.
The total T 4 and T 3 contents in the thyroid gland of fetuses from the different treatment groups did not correlate with their changes in F-plasma or F-tissues. The changes observed in the concentrations of T 4 and T 3 in the F-tissues were similar to those in the corresponding hormone in F-plasma, as the F-tissue to F-plasma ratios (not shown) were usually the same as those in fetuses from C dams, except for T 3 in F-liver, F-lung, and F-brain in the Dϩ1.0 Ins group, which was lower than expected from the F-plasma levels.
Changes in the thyroid hormone status of the fetuses from D groups were similar to those in their mothers. On the contrary, the effects of insulin treatment on T 4 and T 3 concentrations were different. Treatment of the D dams with insulin usually resulted in insulin dose-dependent changes, whereas there was no clear relationship between the insulin dose and fetal T 4 and T 3 concentrations. There was also no correlation between the changes in thyroid status of the fetuses and F-plasma insulin. As indicated above, there was a better correlation with F-BW and pituitary GH content.
The activities of 5ЈD-I in F-liver and F-lung and of 5ЈD-II and 5D-III in F-brain, either did not correlate with the T 4 and T 3 in F-plasma or in F-liver and F-lung, or did so poorly, with r values of 0.5 or less. No clearly significant correlations were found between these enzyme activities and the F-plasma glucose levels. Changes in the activities of 5ЈD-I in F-liver and F-lung and 5ЈD-II in F-brain were less marked than those in the corresponding maternal tissues.
Discussion
Present results confirm and extend our preliminary observations on the effects of maternal STZ-induced diabetes mellitus on fetal thyroid hormone status, as studied on 20 dg (11), which are likely to result from the altered carbohydrate metabolism of their mothers, and not from a direct destructive action of STZ on the fetal pancreas. The half-life of disappearance of STZ from the circulation is 5 h in rodents (23) . The drug, injected at 7 dg, would no longer be present by the time the ␤-cells of the fetal pancreas develop in the rat (12.5-13.5 dg), long before the morphological structure of the ␤-cells is achieved on 18 dg (24) . Moreover, when maternal hyperglycemia was mitigated with insulin, F-plasma insulin was normal, indicating that fetal ␤-cells were functional. As the placenta is impermeable to maternal insulin (25) , this would not occur if the fetal pancreas had been directly affected by the drug. The pancreas of the hyperglycemic fetuses of the present D dams showed hyperplasia, hypertro- phy, and degranulation of immunochemically identified insulin-positive ␤-cells (our unpublished data), confirming the findings of others (26) and indicating ␤-cell overstimulation and exhaustion.
A direct toxic effect of STZ on the placenta is also unlikely. Ultrastructural changes in the placenta have been described, but were less frequent when insulin was supplied (27) , whereas a direct toxic effect would be independent from treatment with insulin. In a previous study (unpublished) in which the rats were treated with STZ before conception and maintained with insulin until midgestation, we found the same changes in the concentrations of both T 4 and T 3 in the M-placenta as those described here for dams treated with STZ during pregnancy; T 4 decreased to 16% of C values, and T 3 to 63%. The F-BW of the dams given STZ pregestationally was similarly affected as that of the present D fetuses, decreasing to 67% of C values.
The pregnant rat with diabetes mellitus as a model of maternal nonthyroidal illness
The changes in thyroid hormone status occurring in nonthyroidal illness are at present considered adaptive responses to a limited availability of intracellular energy, a situation in which a decrease in T 3 -dependent catabolic effects would be beneficial (1, 2) . Several mechanisms are involved in these responses, of which two are best known, namely 1) a decreased thyroidal secretion of both T 4 and T 3 , which would lower the pool of T 4 available for extrathyroidal generation of T 3 , and 2) a decrease in the activity of enzymes involved in the extrathyroidal generation of T 3 from T 4 .
1) The sequence of events involves decreased release of hypothalamic TRH (4, 5) , secretion of TSH (4, 6, 7) , and sensitivity of the thyroid to TSH (6) , which supersede the normal feedback mechanism; TSH decreases despite the lower levels of circulating total and/or free T 4 and T 3 . Indeed, a return to a normal secretion of TSH and thyroidal release of hormones is considered an indication that the illness is remitting or that the metabolic alterations are under control. The present changes in circulating total and free T 4 and T 3 together with decreased TSH and the low T 4 and T 3 levels found in all of the tissues studied are in agreement with the changes described in the nonpregnant diabetic rats (8) and in patients dying from nonthyroidal illnesses (28) .
2) Direct measurement of 5ЈD-I activities in the liver and lung has confirmed that generation of T 3 from T 4 is decreased in diabetic rats (11, 29, 30) and is consistent with a decreased expression of 5ЈD-I messenger RNA (29) . 5ЈD-II activity in the cerebral cortex of D dams was not changed, possibly because cerebral T 4 was not decreased, and confirming the lack of change described in nonpregnant diabetic rats (10, 31) .
Treatment with insulin: varying severity of maternal illness
The diabetic state of the dams improved. The best results were observed in the Dϩ0.5 Ins group both with respect to parameters of diabetes mellitus and reproductive competence and with respect to thyroid hormone status, including circulating TSH and liver and lung 5ЈD-I activities.
The two higher doses of insulin used in the present study might well have been excessive; the glucose and insulin levels were normal 24 h after the last injection, suggesting daily periods of hypoglycemia. Most, but not all, changes in parameters of maternal thyroid hormone economy appeared to be insulin dose dependent.
Effects on the placenta
In diabetic women and rats, hyperglycemia increases placental weight and placental glycogen content (32) . The placentas from the present D dams were clearly affected. It is very difficult to properly regulate placental function and fetal metabolism in diabetic mothers with insulin (33) administered once daily, 2 possibly because of the daily cycles of hyper-and hypoglycemia, or constant hypoglycemia. These were more likely to occur in the Dϩ1.0 Ins and Dϩ1.5 Ins dams. Indeed, the best results were observed in the Dϩ0.5 Ins dams, which were not likely to have undergone prolonged periods of hypoglycemia.
The placenta plays a very important role in the supply of nutrients and in determining the metabolic status of the fetus. Posner et al. (34) suggested that insulin might promote substrate transport across the placenta, which has insulin receptors. The rat placenta is permeable to maternal T 4 and T 3 (13, 14) and is active in the local metabolism of both iodothyronines, as it contains iodothyronine deiodinase isoenzymes, with 5ЈD-II activity highest in the M-placenta (35), and 5-III highest in the F-placenta (36) .
Although T 4 and T 3 decreased in the placenta of D dams and reversed to normal or supraphysiological levels with insulin treatment, the changes occurring in the M-placenta were quantitatively different from those found in M-plasma. T 4 concentrations decreased more than expected from the changes in circulating total T 4 or FT 4 , in agreement with our previous report (11) . The opposite was observed for the concentrations of T 3 in the M-placenta, which increased more with insulin treatment than expected from the circulating changes in total T 3 and FT 3 . The differences in thyroid hormone status of the M-placenta compared to other M-tissues may well be related to the decreased uteroplacental blood flow caused by a significant reduction in the arterial blood velocity in the uterine artery, placenta, umbilical artery, and fetal aorta (37) . The mechanisms, if any, regulating placental permeability to the iodothyronines and their metabolism in the M-and F-placenta are unknown at present, so that the possibility that their transfer is altered by the hyperglycemic state or the lack of insulin has not yet been studied. Changes in the activities of the different iodothyronine-deiodinating isoenzymes may also contribute to the observed concentrations, but were not defined in the present experiment.
Effects on fetal development and thyroid hormone status
The reproductive competence of the present STZ-induced diabetes mellitus pregnant rats was impaired, not only with regard to the decreased number of fetuses per litter and the increased frequency of resorptions, but also with respect to the development of their fetuses, as assessed by BW. In our study, the F-BW was significantly reduced in fetuses from all groups of STZ-injected dams, in agreement with the severity of the diabetes and with reports by others using models similar to the present one (12, 26) or with pregestational diabetes (38) and data of babies born from poorly controlled diabetic women (39 -41) . The growth impairment that exists in the adult rat with diabetes mellitus is attributed at least in part to decreased pituitary GH content and secretion (7) resulting from decreased GH messenger RNA and decreased GH transcription rate (42) . Although the control of fetal growth is not usually attributed to fetal GH, but to insulinlike growth factors, the pituitary content of this hormone was lower in the fetuses from the D dams of the present study and was closely correlated to their F-BW.
The changes in F-plasma glucose levels were clearly related to those in the maternal circulation, as previously shown by others in rats (12) and sheep (43) , as they have a limited capacity to handle the glucose coming from their hyperglycemic mothers. It is quite likely that the hyperglycemia of the D fetuses was responsible for exhaustion of an overstimulated fetal pancreas (26) , resulting in decreased F-plasma insulin levels (11, 12) . The thyroid hormone status of the fetus was clearly affected by the maternal diabetes mellitus, with regard to both intrathyroidal T 4 and T 3 contents and extrathyroidal pools; both were markedly reduced. Morphological parameters, such as the decreased area of epithelial cells, were consistent with a dormant thyroid in fetuses from D dams (our unpublished observations), as described for adult rats. This is in conceptual agreement with the finding that insulin is essential for the transcription of two thyroid-specific genes, namely the thyroglobulin and thyroid peroxidase genes (44, 45) .
In fetuses from D dams, the concentrations of T 4 and T 3 were reduced in the circulation and all tissues studied, including the carcass, with the total extrathyroidal stores reduced to one third of C values. This might not only be due to decreased secretion by the fetal thyroid, but also to the decrease in maternal T 4 and T 3 pools available for transport (46) into the fetal compartment. A decreased availability of maternal hormones could be aggravated by effects of the maternal diabetes mellitus on M-placental function.
Whatever the relative roles played by the different mechanisms, the hyperglycemic fetuses presented all of the changes found in their mothers, including an increased % FT 4 and decreased liver and lung 5ЈD-I activities. 5ЈD-II activity in the fetal brain did not show the increase expected from the low F-plasma and F-brain T 4 (13) (14) (15) (16) , as a result of which cerebral T 3 concentrations were lower than those in normal fetuses.
In contrast, the effects of insulin treatment of the dams on fetal weight, circulating insulin levels, and thyroid hormone economy did not parallel those observed in their mothers. The different doses of insulin resulted in a normal increase in the M-BW in all three groups of insulin-treated D dams and dose-related increases in circulating insulin. The concentrations of T 4 and T 3 in M-plasma and most tissues also appeared to increase with increasing insulin doses. In contrast, a clear improvement in F-BW was only observed in the Dϩ0.5 Ins group, the only group in which the number of fetuses per litter was normal and resorptions absent and in which F-plasma insulin levels were restored to normal values. Despite this improvement, a normal F-BW was not attained, in agreement with previous reports (11, 12) . A normal fetal pituitary GH content was not attained with any of the insulin doses used in the present study. Although the fetal pituitary GH content was not measured, Erikson et al. (38) did not find normal F-BW when rat dams, injected with STZ weeks before the onset of pregnancy, were treated with insulin. We cannot at present explain these results and cannot exclude a direct effect of STZ, injected on day 7 of gestation into the mothers, on the fetal pituitary. This appears unlikely, considering that the decrease in pituitary GH in adult STZtreated rats is corrected with insulin (7). Maternal hyperinsulinemia (47) and intermittent hypoglycemia (48) also affect fetal growth, and it is likely that such events accounted for the poor results obtained by us with the higher insulin doses, considering that Ultralente insulin was used in the present study.
3 F-BW in these groups was closely related to their pituitary GH content, not to F-plasma glucose or insulin levels. F-plasma insulin levels decreased with the increasing dose of insulin injected into their mothers and were as low as those in fetuses from D dams in the hypoglycemic fetuses of the Dϩ1.5 Ins dams, possibly because of continuous overstimulation leading to exhaustion of their ␤-cells.
Most parameters of thyroid status improved or actually reverted to normal values in the fetuses from the Dϩ0.5 Ins dams, including attainment of normal T 3 concentrations in the F-brain. The changes in T 4 and T 3 in the F-thyroid, Fplasma, and F-tissues did not appear to be dose dependent with respect to the insulin administered to their mothers, being often more closely related to the F-BW and pituitary GH content. If the latter parameters are taken as indexes of fetal metabolic abnormalities and intracellular energy availability, it would appear that if adequate control of the maternal diabetic condition were achieved, the alterations in fetal thyroid hormone economy, including brain T 3 levels, would be avoided.
Possible clinical relevance of the present findings
Fetal damage, abnormalities, and resorptions are well known hazards of diabetes in pregnancy, whether in human or experimental models (38, 49) , especially when inadequately controlled, as evidenced by increased maternal ␤-hydroxybutyrate and triglyceride levels. Rizzo et al. (50) reported that diabetes mellitus during pregnancy affects the intellectual development and behavior of the progeny. They found a correlation between the alterations in lipid metabolism of pregnant woman and the intelligence quotient of their 2-to 3-yr-old children; the higher the levels of ␤-hydroxybutyrate and FFA, the lower the intelligence quotient of the offspring. Considering that if the present results are pertinent to man, brain T 3 might have been low during a phase of development when thyroid hormones are of great importance for brain development, it is possible that alterations in fetal thyroid hormone status are contributing to this intellectual impairment. Unfortunately, although the present results would indicate that adequate control of the diabetes mellitus appears to be of prime importance to prevent the decrease in cerebral T 3 , such control is not easily achieved.
Relevance of present findings for nonthyroidal illness other than diabetes mellitus
The diabetic dam displayed all of the changes in thyroid hormone status considered typical of nonthyroidal illness, changes that could be modulated and/or totally corrected with insulin. We cannot at present exclude that some of the effects observed in both the dams and the conceptus were specifically related to the shortage of insulin and would not be found in other models of nonthyroidal illness. However, the changes in the concentrations of T 4 in the circulation and tissues of nonpregnant STZ-induced diabetes mellitus and food-restricted rats have been shown to be related to energy availability, as measured by the changes in BW, and not specifically to the insulin levels (8) . The same was found for the concentration of T 3 in brain, cerebellum, liver, and pituitary, whereas the T 3 level in brown adipose tissue, heart, muscle, and kidney were more specifically related to the availability of insulin. Although the present experimental design was not adequate to distinguish between the effects of energy shortage and the lack of insulin, the findings we report here may be relevant for other nonthyroidal illnesses in which intracellular energy availability is impaired.
Conclusions
The present results show that maternal diabetes mellitus and possibly maternal nonthyroidal illnesses compromising intracellular energy availability result in severe impairment of the thyroid hormone status of the fetus. This includes low cerebral concentrations of T 3 during a critical period of brain development. Correction of the illness is necessary to protect the brain, as compensatory mechanisms usually involved in maintaining cerebral T 3 homeostasis do not appear to be operative.
